Apnimed, Inc. APMD
16.63 USD -0.15 (-0.89%)
At closeNov 12, 2026, 4:00 PM EST
16.63 0.00 0.00%
After hours · Nov 12, 4:00 PM ET
16.16 Day range 16.99
13.88 52-week range 35.29
- YTD
- -33.48%
- 1 year
- -33.48%
News
globenewswire.com Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Apnimed, Inc. (Nasdaq: APMD) (“Apnimed” or the “Company”), a late-stage clinical pharmaceutical company dedicated to the discovery, development and…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Greenland Mines (NASDAQ:GRML) stock rose 232.6% to $9.48 during Monday's regular session. The company's market cap stands at $9.0 million. GRAIL (NASDAQ:GRAL) shares moved upwards by 31.47%…
benzinga.com Apnimed Q2 EPS $3.91 Beats $(0.34) Estimate, Sales $12.080M Apnimed (NASDAQ:APMD) reported quarterly earnings of $3.91 per share which beat the analyst consensus estimate of $(0.34) by 1250 percent. The company reported $12.080 million in sales this quarter.
benzinga.com LifeSci Capital Initiates Coverage On Apnimed with Outperform Rating, Announces Price Target of $50 LifeSci Capital analyst Francois Brisebois initiates coverage on Apnimed (NASDAQ:APMD) with a Outperform rating and announces Price Target of $50.
benzinga.com This Agomab Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday Analysts change outlook on top names. See all rating changes, including upgrades/downgrades/initiations. Coverage initiated on various stocks.
benzinga.com Cantor Fitzgerald Initiates Coverage On Apnimed with Overweight Rating, Announces Price Target of $60 Cantor Fitzgerald analyst Josh Schimmer initiates coverage on Apnimed (NASDAQ:APMD) with a Overweight rating and announces Price Target of $60.- benzinga.com B of A Securities Initiates Coverage On Apnimed with Buy Rating, Announces Price Target of $41 B of A Securities analyst Jason Gerberry initiates coverage on Apnimed (NASDAQ:APMD) with a Buy rating and announces Price Target of $41.
benzinga.com AstraZeneca, GameStop, Snap And Other Big Stocks Moving Lower In Monday’s Pre-Market Session U.S. stock futures higher, AstraZeneca dips on merger talks, Apple down 7.4%, other stocks moving lower in pre-market trading.
benzinga.com Why Atkore Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket Atkore Inc (ATKR) shares rise on strong Q3 results and acquisition by Prysmian for $95.00 per share. Other gainers include UPC, YYAI, RITR, FCUV, SGLY, FNGR, ALAR, FERG, and BMY while FMFC, PWCM,…